Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 27
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Page, Amy Theresa Potter, Kathleen Clifford, Rhonda and Etherton-Beer, Christopher 2016. Deprescribing in older people. Maturitas, Vol. 91, p. 115.

    Page, Amy T. Clifford, Rhonda M. Potter, Kathleen Schwartz, Darren and Etherton-Beer, Christopher D. 2016. The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis. British Journal of Clinical Pharmacology,

    Rajkumar, Anto P. Ballard, Clive Fossey, Jane Corbett, Anne Woods, Bob Orrell, Martin Prakash, Rohan Moniz-Cook, Esme and Testad, Ingelin 2016. Apathy and Its Response to Antipsychotic Review and Nonpharmacological Interventions in People With Dementia Living in Nursing Homes: WHELD, a Factorial Cluster Randomized Controlled Trial. Journal of the American Medical Directors Association, Vol. 17, Issue. 8, p. 741.

    van der Putten, M.J.G. Wetzels, R.B. Bor, H. Zuidema, S.U. and Koopmans, R.T.C.M. 2014. Antipsychotic drug prescription rates among Dutch nursing homes: the influence of patient characteristics and the dementia special care unit. Aging & Mental Health, Vol. 18, Issue. 7, p. 828.

    Azermai, M. Petrovic, M. Engelborghs, S. Elseviers, M.M. Van der Mussele, S. Debruyne, H. Van Bortel, L. and Stichele, R.H. Vander 2013. The effects of abrupt antipsychotic discontinuation in cognitively impaired older persons: A pilot study. Aging & Mental Health, Vol. 17, Issue. 1, p. 125.

    Declercq, Tom Petrovic, Mirko Azermai, Majda Vander Stichele, Robert De Sutter, An IM van Driel, Mieke L Christiaens, Thierry and Declercq, Tom 2013. Cochrane Database of Systematic Reviews.

    Seitz, Dallas P. Gill, Sudeep S. Herrmann, Nathan Brisbin, Sarah Rapoport, Mark J. Rines, Jenna Wilson, Kimberley Le Clair, Ken and Conn, David K. 2013. Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review. International Psychogeriatrics, Vol. 25, Issue. 02, p. 185.

    Hill, Keith D. and Wee, Rohan 2012. Psychotropic Drug-Induced Falls in Older People. Drugs & Aging, Vol. 29, Issue. 1, p. 15.

    Tamura, Bruce K. Bell, Christina L. Inaba, Michiko and Masaki, Kamal H. 2012. Factors Associated With Polypharmacy in Nursing Home Residents. Clinics in Geriatric Medicine, Vol. 28, Issue. 2, p. 199.

    Chan, Tuen-Ching Luk, James Ka-Hay Shea, Yat-Fung Lau, Ka-Hin Chan, Felix Hon-Wai Yu, Gabriel Ka-Kui and Chu, Leung-Wing 2011. Continuous use of antipsychotics and its association with mortality and hospitalization in institutionalized Chinese older adults: an 18-month prospective cohort study. International Psychogeriatrics, Vol. 23, Issue. 10, p. 1640.

    Scheifes, A. Stolker, J. J. Egberts, A. C. G. Nijman, H. L. I. and Heerdink, E. R. 2011. Representation of people with intellectual disabilities in randomised controlled trials on antipsychotic treatment for behavioural problems. Journal of Intellectual Disability Research, Vol. 55, Issue. 7, p. 650.

    Kleijer, Bart C. Marum, Rob J. Egberts, A.C.G. (Toine) Jansen, Paul A.F. Frijters, Dinnus H.M. Heerdink, E.R. (Rob) and Ribbe, Miel W. 2010. Het beloop van gedragsproblemen bij oudere verpleeghuispatiënten met dementie die worden behandeld met antipsychotica. Tijdschrift voor ouderengeneeskunde,

    Parsons, Carole Hughes, Carmel M. Passmore, A. Peter and Lapane, Kate L. 2010. Withholding, Discontinuing and Withdrawing Medications in Dementia Patients at the End of Life. Drugs & Aging, Vol. 27, Issue. 6, p. 435.

    Eggermont, Laura H. P. de Vries, Kerst and Scherder, Erik J. A. 2009. Psychotropic medication use and cognition in institutionalized older adults with mild to moderate dementia. International Psychogeriatrics, Vol. 21, Issue. 02, p. 286.

    Kleijer, B. C. van Marum, R. J. Egberts, A. C. G. Jansen, P. A. F. Frijters, D. Heerdink, E. R. and Ribbe, M. 2009. The course of behavioral problems in elderly nursing home patients with dementia when treated with antipsychotics. International Psychogeriatrics, Vol. 21, Issue. 05, p. 931.

    Cohen-Mansfield, Jiska and Jensen, Barbara 2008. Assessment and Treatment Approaches for Behavioral Disturbances Associated With Dementia in the Nursing Home: Self-Reports of Physicians' Practices. Journal of the American Medical Directors Association, Vol. 9, Issue. 6, p. 406.

    Iyer, Shoba Naganathan, Vasi McLachlan, Andrew J and Le Couteur, David G 2008. Medication Withdrawal Trials in People Aged 65 Years and Older. Drugs & Aging, Vol. 25, Issue. 12, p. 1021.

    Ruths, Sabine Straand, Jørund Nygaard, Harald A. and Aarsland, Dag 2008. Stopping antipsychotic drug therapy in demented nursing home patients: a randomized, placebo-controlled study--The Bergen District Nursing Home Study (BEDNURS). International Journal of Geriatric Psychiatry, Vol. 23, Issue. 9, p. 889.

    Herrmann, Nathan Gauthier, Serge and Lysy, Paul G. 2007. Clinical practice guidelines for severe Alzheimer’s disease. Alzheimer's & Dementia, Vol. 3, Issue. 4, p. 385.

    Koopmans, R. T. C. M. 2007. Worden psychofarmaca in het verpleeghuis te vaak voorgeschreven?. Tijdschrift voor Gerontologie en Geriatrie, 2007, Vol. 38, Issue. 6, p. 238.


A Randomized, Placebo-Controlled Trial of the Discontinuation of Long-Term Antipsychotics in Dementia

  • Robert van Reekum (a1) (a2), Diana Clarke (a1) (a3), David Conn (a1) (a2), Nathan Herrmann (a2) (a4), Goran Eryavec (a5), Tammy Cohen (a1) and Laurie Ostrander (a1)
  • DOI:
  • Published online: 01 June 2002

The objectives of this randomized clinical trial were to investigate the impact of the discontinuation of long-term antipsychotics in residents with dementia in chronic care institutions and to identify clinical predictors of safe discontinuation. Subjects included 34 residents with dementia who were on antipsychotics for more than 6 months and whose behavior was currently stable. Subjects were randomized to either continue receiving their regular dosage of antipsychotics or to receive placebo for 6 months. Early withdrawal from the study was not statistically different between the groups (relative risk [RR] = 1.57, 95% confidence interval [CI] 0.76–3.26), and though not significantly different, subjects in the placebo group were more likely to be withdrawn from the study because of worsening behavior (RR = 1.25, 95% CI 0.33–4.76). Three subjects in the placebo group were withdrawn from the study due to worsening of extrapyramidal symptoms. The active treatment group had more behavioral problems (e.g., physical aggression towards others, p < .05) compared to the placebo group. The placebo group developed more apathy, but balancing this outcome was a relative improvement in congitive functioning. Baseline antipsychotic dose was predictive of behavioral worsening upon discontinuation of long-term antipsychotic drugs. The primary limitation of the study was the small sample size. In conclusion, a trial of discontinuation of antipsychotics should be considered in this population.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Psychogeriatrics
  • ISSN: 1041-6102
  • EISSN: 1741-203X
  • URL: /core/journals/international-psychogeriatrics
Please enter your name
Please enter a valid email address
Who would you like to send this to? *